Porin of Shigella dysenteriae was incorporated in liposome (PIL) and presented to mouse splenic dendritic cells (DC). PIL up-regulated Toll-like receptor (TLR) 2 and TLR6 on DC, showing that coexpression of the two TLRs is involved in recognition of porin. Detection of myeloid differentiating factor 88 (MyD88)-TLR2 complex confirmed interaction between the two for triggering the downstream signaling, which ultimately led to TLR2-dependent nuclear translocation of nuclear factor-kappa B. PIL-induced expression of MHC class II (I-A b ), CD40 and CD80 showed maturation of DC, whereas up-regulation of intercellular adhesion molecule-1 and CCR7 implicated the capacity of splenic DC to migrate. Induction of messenger ribonucleic acid for the chemokines, macrophageinflammatory protein (MIP)-1a, MIP-1b and regulated upon activation, normal T cell expressed and secreted indicated a strong bias of PIL for type 1 polarization that was supported by the intracellular expression and release of tumor necrosis factor (TNF)-a and IL-12. Along with CD40 and CD80 expression, release of the cytokines of CD11c 1 JAWS II cells was inhibited by TLR2 or simultaneous TLR2 and 6 knockdown showing that recognition of PIL by the two TLRs is essential for DC activation and type 1 polarization. The signaling pathway initiated upon recognition of PIL by the TLRs was MyD88 dependent as confirmed by inhibition of IL-6, TNF-a and IL-12 release of MyD88-knockdown JAWS II cells. The maturation and polarization of DC induced T h 1 phenotype, as evident from proliferation, activation and IFN-g release of allogeneic CD4 1 T cells in response to PIL-stimulated DC, thereby suggesting that the adjuvant activity of PIL can successfully bridge the innate and adaptive immunity.
Introduction
Porins are major outer membrane proteins with pore-forming ability that are strongly immunogenic and can augment the humoral response to otherwise poorly immunogenic substances (1, 2) . These proteins are of particular interest because they have been characterized as potent adjuvants and have great potential as a novel component of vaccines (3, 4) . Rapid appearance of drug-resistant strains of Shigella spp. (5) evokes the need to study porin as a potential adjuvant to be incorporated in vaccines against shigellosis. The liposomal bilayer made of phospholipids and cholesterol mimics the membrane environment, making liposomes an attractive vehicle for presentation of membrane proteins such as porin of Shigella dysenteriae type 1. Liposomes are well-defined structures excellently suited to nest the porin molecule in its native form and be delivered as an effective adjuvant. The particulate delivery system both augments the effectiveness of the adjuvant by increasing the amount of antigen that can be presented to the immune cells and also protects the immunogen (6) .
Involving dendritic cells (DC) to study the immunopotentiating activity of porin-incorporated liposome (PIL) would open the window to understand how the adjuvant gets recognized by the innate immune system and finally acts to activate the otherwise blunted adaptive immunity. DC act as sentinels in the tissue where they capture the antigen and initiate the innate immune response. Subsequently, the antigen is processed into smaller peptides as the DC mature and migrate toward secondary lymphoid organs and present the peptides to naive T cells (7) . This leads to activation of T cells, the effectors of adaptive immune response.
Recognition of pathogen-associated molecular pattern (PAMP) by Toll-like receptors (TLRs) of DC triggers the signaling pathway through the Toll IL-1 receptor-containing adaptor protein, myeloid differentiating factor 88 (MyD88) that engage tumor necrosis factor receptor-associated factor 6 (TRAF6), leading to activation of the members of mitogenactivated protein kinase (MAPK) family, such as p38 and c-Jun N-terminal kinase (JNK) and the pro-inflammatory nuclear factor-kappa B (NF-jB) (8, 9) . Upon stimulation by microbial TLR ligand, DC undergo maturation, a process involving its shift from antigen-capturing mode to T cellsensitizing mode, characterized by up-regulation of MHC and co-stimulatory molecules (10) . The maturation process parallels migration of DC, first to the lymphatics and then to the T cell areas of secondary lymphoid organ, which is induced by change in the pattern of expression of adhesion molecules such as intercellular adhesion molecule (ICAM)-1 and chemokine receptors like CCR7 (11) . The combined events of maturation and migration make DC capable of priming naive T cells.
Mature DC not only activate T cells but also trigger a distinct set of cytokines and chemokines that drives T cell polarization into T h 1, T h 2 or regulatory T cell subsets. Cytokines like IL-12 and tumor necrosis factor (TNF)-a pave the way for T h 1 polarization, while IL-10 participates in regulatory T cell differentiation (12) . Due to their critical role in inducing T h 1 development, IL-12 production is tightly regulated in DC and found to be initiated by ligation of CD40 with CD40 ligand (CD40L) on T h cells (13) . Among the chemokines that determine T cell polarization, inflammatory chemokines like macrophage-inflammatory protein (MIP)-1a (CCL3), MIP-1b/ CCL4, regulated upon activation, normal T cell expressed and secreted [(RANTES)/CCL5] are preferentially expressed by T h 1-promoting DC (14) thus inducing type 1 response. Similarly, thymus and activation-related chemokine [(TARC)/ CCL17], macrophage-derived chemokine (MDC/CCL22) and eotaxin-2/CCL24 are found to be associated with polarized type 2 response (15) .
In this paper, we show PIL up-regulated TLR2 and 6 on DC. Following the recognition of PIL by TLRs, involvement of the downstream signaling molecules ultimately leading to the nuclear translocation of NF-jB and induction of the costimulatory molecules were assessed to determine activation of DC. The matured DC expressed type 1 chemokines and released TNF-a and IL-12, suggesting PIL-induced DC1 phenotype. The PIL-pulsed DC activated the naive allogeneic CD4
+ T cells for T h 1-type response.
Methods

Immunogen
Porin was purified to homogeneity from S. dysenteriae type 1 (strain A020332) (16) . The protein was free from LPS, which could not be detected by estimation of neutral sugar, ester content and Limulus amebocyte lysate assay (17) . The protein was incorporated into artificial liposome vesicles as described elsewhere (16) . Briefly, a mixture of 2.6 lM egg yolk phosphatidylcholine (Sigma, St Louis, MO, USA) and 0.1 lM dicetylphosphate in 9:1 chloroform:methanol was mixed and dried in vacuo to form a film. The film was sonicated in the presence of 207 lg porin by applying 25 brief pulses. The liposomes were prepared by lyophilizing and dissolving porin and the phospholipid mixture in 5 mM TrisHCl, pH 7.4. PIL was applied on a Sepharose CL-4B column (0.8 3 19 cm) pre-equilibrated with 5 mM Tris-HCl (pH 7.5) containing 0.1 M NaCl. One milliliter fractions were collected at a flow rate of 10 ml h À1 and A 280 of the eluent was recorded. Pore-forming activity of PIL was measured by the liposome-swelling method as described elsewhere (16) . Prior to electrophoresis, protein concentration of PIL was estimated by the bicinchoninic acid method using BSA as the standard. Phosphate content of the preparation was estimated by the ammonium molybdate-ascorbic acid method, using NaH 2 PO 4 as standard (18) . Blank liposomes were prepared with the lipid mixture in absence of porin in 5 mM Tris-HCl (pH 7.4)-0.04% SDS to serve as control.
Animal
C57BL/6 and BALB/c mice were obtained from National Centre for Laboratory Animal Sciences, National Institute of Nutrition, Jamai-Osmania, Hyderabad, India and maintained in the animal care facility of the National Institute of Cholera and Enteric Diseases, Kolkata. The mice were housed in groups of five and given food and water ad libitum. The experiments with animals were conducted in accordance with the Animal Ethical Committee guidelines of National Institute of Cholera and Enteric Diseases, Kolkata.
Culture of DC
Splenic DC were isolated from 6-week-old C57BL/6 mice according to the method of Steinman et al. (19) . Briefly, single cell suspension was prepared after passing through 105-lm nylon mesh, which was depleted of erythrocytes. Splenocyte population was enriched in DC by equilibrium density centrifugation at 9000 3 g for 15 min in dense (30%) BSA. Low-density floating cell subpopulation obtained was seeded in six-well flat-bottomed tissue culture polystyrene plates (Corning Inc., Corning, NY, USA), at 8 3 10 6 cells per 3 ml per well in R-5 medium, containing RPMI-1640 (Gibco, Invitrogen Corp., Grand Island, NY, USA) with 100 U ml À1 penicillin, 100 lg ml À1 streptomycin, 50 lg ml À1 gentamicin, 5% fetal bovine serum (FBS) and 55 lM 2-ME (Sigma) and incubated at 37°C in 5% CO 2 for 2.5 h. The non-adherent cells were removed and the adherent cells were incubated in R-1 medium (R-5 medium with 10 ng ml À1 recombinant mouse granulocyte macrophage colonystimulating factor (GM-CSF); BD Biosciences Pharmingen, San Diego, CA, USA) for 24 h. After incubation, loosely adherent cells were labeled with CD11c MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and purified by AutoMACS (Miltenyi Biotec) using the Positive Selection program. The CD11c + cells were seeded in 96-well flat-bottomed plates at 0.2 3 10 6 cells per 0.2 ml per well in R-2 medium, containing RPMI-1640, 2% FBS, antibiotics and 0.1% insulintransferrin-selenium, and cultured with PIL (having 10 lg protein for a million DC), blank liposomes (with phosphate content equivalent to PIL), 0.5 lg ml À1 FSL-1 (Pam 2 CGDPKHPKSF) (InvivoGen, San Diego, CA, USA), 5 lg ml À1 Pam 3 CSK 4 or 100 ng ml À1 LPS (Escherichia coli 0111:B4) (Sigma). For inhibition studies, DC were incubated with either 10 lg ml À1 purified anti-mouse TLR2 antibody (Functional Grade; eBioscience Inc., San Diego, CA, USA) or 50 lg ml À1 NF-jB inhibitor (synthetic inhibitor, AAVALLPAVLLALLAPVQRKRQKLMP, inhibits translocation of NF-jB active complex into the nucleus) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 30 min prior to the addition of PIL. Cells were treated with 20 U per well IFN-c or 2 lg per well agonistic anti-CD40 antibody (BD Biosciences Pharmingen) for augmentation of PIL-induced cytokine expression.
Allogeneic mixed leukocyte reaction
Naive splenic CD4
+ T cells of BALB/c mice were obtained by sorting on AutoMACS using CD4 T cell isolation kit (Miltenyi Biotec) and CD62L (L-selectin) MicroBeads. DC cultured with blank liposomes or PIL were incubated for 1 h with 40 lg ml À1 of mitomycin-C (Sigma) and washed with R-5 medium prior to co-culture with 0.2 3 10 6 per well of naive allogeneic CD4
+ T cells. After 3-day co-culture, proliferative response of the T cells was determined by 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide assay as described elsewhere (17) .
Immunoprecipitation and immunoblot
PIL-treated DC were lysed in cold lysis buffer (Cell Signaling Technologyâ, Beverly, MA, USA), centrifuged to clear the debris and incubated with rabbit anti-TLR2 antibody (Santa Cruz Biotechnology, Inc.)-bound Protein A Sepharose TM CL-4B (Pharmacia, Uppsala, Sweden), overnight at 4°C. The antigenantibody-bound beads were centrifuged, washed, boiled in Laemmli sample buffer for 5 min and the immunoprecipitate was separated by SDS-PAGE. The electrophoresed proteins were transferred to nitrocellulose membrane and probed with rabbit anti-MyD88 antibody (Santa Cruz Biotechnology, Inc.) and anti-TLR2 antibody for detection of the respective molecules in MyD88-TLR2 complex. In order to detect phosphorylation of the members of MAPK family and IjBa, the cell lysate was electrophoresed, western blotted and incubated overnight at 4°C with rabbit anti-phospho p38 mAb (Cell Signaling Technologyâ), anti-phospho JNK or antiphospho IjBa antibody and compared with that incubated with rabbit anti-p38, anti-JNK or anti-IjBa antibody, respectively. Rabbit anti-b-actin mAb was used to detect b-actin. The western blots were imaged by incubation with HRPconjugated anti-rabbit IgG and Immobilon TM Western Chemiluminescent HRP Substrate (Millipore Corp., Billerica, MA, USA).
Flow cytometry
DC were stained at 4°C in the dark for 20 min with PE-conjugated anti-mouse CD11c mAb (eBioscience Inc.) followed by any one of FITC-conjugated anti-mouse TLR2 (BD Biosciences Pharmingen), CD40, CD80, CD86, ICAM-1 or CXCR4 mAb, PE-Cy7-conjugated anti-mouse CCR7 mAb (eBioscience Inc.), biotin-conjugated anti-mouse TLR1, TLR4 or MHC class II (I-A b ) mAb. TLR6 expression was detected by goat polyclonal anti-mouse TLR6 antibody (Santa Cruz Biotechnology, Inc.) and FITC-conjugated antigoat IgG. Induction of the activation molecules, CD25 and CD69, on CD4 + T cells in allogeneic mixed leukocyte reaction (MLR) was evaluated by staining with PerCP-conjugated anti-mouse CD4 and FITC-conjugated anti-mouse CD25 or biotinylated anti-mouse CD69 mAbs. Biotinylated mAb was recognized by streptavidin-FITC. Cells were analyzed on a FACSCalibur using CELLQuest software (Becton Dickinson, San Jose, CA, USA).
Analysis of NF-jB translocation
Nuclei, prepared from one million DC cultured with blank liposomes or PIL for 45 min, were stained and NF-jB translocation on the nuclei was analyzed by flow cytometry as described elsewhere (20) .
Intracellular staining of cytokines
PIL-treated DC were incubated with Brefeldin A (20 ll ml À1 ) (BD Biosciences Pharmingen) for the last 6 h of culture to inactivate the Golgi apparatus and prevent cytokine secretion. The cells were stained with PE-conjugated anti-mouse CD11c mAb and intracellular expression of IL-10, TNF-a and IL-12 was analyzed by flow cytometry as described elsewhere (20) . Statistical analysis was done by using isotype-matched controls as a reference (M1).
Cytokine ELISA IL-6 and TNF-a in 24-h-old, IL-10 and IL-12 p70 in 48-h-old DC culture supernatant, and IFN-c and IL-4 in supernatant of 5-day allogeneic MLR were measured in sandwich ELISA with pairs of Abs for binding and detection using BD OptEIA ELISA kits according to the manufacturer's instructions (BD Biosciences Pharmingen).
Reverse transcription-PCR analysis
Total RNA was isolated from 1 3 10 6 DC treated with PIL or blank liposomes using RNAqueous TM -4PCR kit (Ambion Inc., Austin, TX, USA) and reverse transcribed using RETROscript TM kit. cDNA served as template for the amplification of TLRs, signaling molecules, chemokines and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts by PCR in an automated thermal cycler (Applied Biosystems GeneAmp PCR System 2700, Foster City, CA, USA) using SuperTaq TM polymerase and the corresponding primers as described elsewhere (20, 21) . Primers for MIP3b-forward: 5#-AGCCTTCCGCTACCTTCTTA-3#; reverse: 5#-GTACCAAGCGGCTTTTATTG-3# and secondary lymphoid tissue chemokine [(SLC)/CCL21]-forward: 5#-CAAGTT-TAGGCTGTCCCATC-3#; reverse: 5#-ATTCCCTGGGAGA-CACTCTT-3# were used for amplification. Control PCRs were performed to ensure that non-specific amplification did not occur. The images were captured using a gel documentation system (UVP, Upland, CA, USA). The amplified reverse transcription (RT)-PCR products were normalized for the relative quantity of the amplified RT-PCR product of GAPDH using UVP Labwork software of the gel documentation system. Changes in messenger ribonucleic acid (mRNA) expression were presented as mean fold induction by PIL relative to the blank liposomes.
Transfection of JAWS II cell for knockdown of TLR2, TLR6 and MyD88
JAWS II cells (American Type Tissue Culture Collection, Manassas, VA, USA), an immature mouse DC line, were cultured in complete alpha-MEM-containing ribonucleosides and deoxyribonucleosides (Gibco, Invitrogen Corp.), 20% FBS, 4 mM L-glutamine, 5 ng ml À1 recombinant mouse GM-CSF, 100 U ml À1 penicillin, 100 lg ml À1 streptomycin and 50 lg ml À1 gentamicin. The cells were grown overnight to 50-60% monolayer confluency in 24-well plates (Corning Inc.) and transfected with 2 lg shRNA vectors (InvivoGen) directed against TLR2 (GTGCCCTTCTCCTGTTGATCT; psiRNA-mTLR2/TLR2 shRNA) or luciferase protein (GACT-TACGCTGAGTACTTCGA; psiRNA-LucGL3/control shRNA), as a negative control, using TransIT-TKO â transfection reagent (Mirus Bio Corp., Madison, WI, USA) (22) . Both the vectors also encoded green fluorescent protein (GFP). Similarly, JAWS II cells were transfected with 25 nM duplex siRNA directed against TLR6 (5#-GGAAUGGUUUGAAGAACUUtt-3#) (Ambion Inc.), MyD88 (5#-CGUUCUCUACCAUAGAGGCtt-3#) or Negative Control siRNA (scrambled sequence). Both TLR2 shRNA and TLR6 siRNA were applied for simultaneous knockdown of TLR2 and 6. The siRNAs were labeled with fluorescein (FAM TM , Ambion Inc.) using Silencerâ siRNA Labeling Kit (Ambion Inc.) prior to transfection, for determining the transfection efficiency. Eighty-five percent of the cells remained viable 36 h after transfection to which PIL or blank liposomes was added.
Expression of MyD88 in transfected and non-transfected cells was analyzed by western blotting using rabbit antiMyD88 antibody and chemiluminescent substrate. The cells were analyzed for CD11c, TLR2, TLR6, CD40 and CD80 expression by flow cytometry after incubation with PEconjugated anti-mouse CD11c (eBioscience Inc.), TLR2, CD40 or CD80 mAb or polyclonal TLR6 antibody and FITCconjugated anti-goat IgG. Release of IL-6 and TNF-a in cellfree supernatant was quantified 24 h and that of IL-12 p70 48 h of PIL treatment by ELISA.
Statistical analysis
Results were expressed as the mean 6 standard error of the mean (SEM) where applicable of three independent experiments. The data were analyzed by Student's t-test using a web-based program (http://www.statpages.net). A P-value of <0.05 was considered significant and a P-value of <0.005 was considered highly significant.
Results
Purification of PIL
Size exclusion chromatography of PIL on Sepharose CL-4B yielded a single peak (Fig. 1A) demonstrating homogeneous size of the preparation. Electrophoresis of PIL after boiling at 100°C for 20 min showed presence of the porin monomer at 38 000 (Fig. 1B) . Occurrence of the oligomer at 78 000 indicates that insertion of porin in the artificial liposome vesicle prevented the protein from being totally reduced to the monomer by boiling. Thereby, the data ascertain proper incorporation of the protein into the liposomes.
PIL induces TLR2 and TLR6 expression of DC
Splenic DC of C57BL/6 mice were cultured for 24 h in presence of PIL, FSL-1, Pam 3 CSK 4 or LPS. Analysis of relative fluorescence intensity showed 2.8-fold (2.83 6 0.39 SEM, P < 0.05) increase in TLR2 and 2-fold (2.2 6 0.31 SEM, P < 0.05) increase in TLR6 expression by PIL compared with the cells treated with blank liposomes (Fig. 2A ). TLR2 and TLR6 were up-regulated by 4-(3.9 6 0.62 SEM, P < 0.05) and 2.4-fold (2.4 6 0.28 SEM, P < 0.05), respectively, in presence of the known TLR2/TLR6 ligand FSL-1. The TLR2/ TLR1 ligand Pam 3 CSK 4 up-regulated TLR2 and TLR1 expression by 5-(4.8 6 0.51 SEM, P < 0.05) and 2-fold (1.87 6 0.32 SEM, P < 0.05), respectively, while the TLR4 ligand LPS induced 4-fold (4.1 6 0.43 SEM, P < 0.05) increase in TLR4 expression. However, TLR1 and TLR4 expression remained unaffected with PIL treatment of DC. RT-PCR was conducted using TLR1, TLR2 and TLR6 primers with total RNA isolated from DC after incubation for 24 h with PIL or blank liposome (Fig. 2B) . The data show that TLR2 and TLR6 were expressed 2.5-(2.5 6 0.1 SEM, P < 0.005) and 1.9-fold (1.88 6 0.06 SEM, P < 0.05) more than control. PIL thus up-regulated TLR2 and TLR6 similar to FSL-1, indicating that TLR6 and not TLR1 participate in combination with TLR2 for distinguishing the protein.
PIL activates TLR2 signal transduction
Up-regulation of TLR2 on DC in response to PIL led us to investigate the effect of the protein on TLR2 activation and subsequent triggering of the downstream signaling pathway. We examined the time-dependent association of the adaptor molecule MyD88 with TLR2 after exposure to PIL. MyD88-TLR2 complex was detected within 15 min of PIL treatment that persisted till 60 min (Fig. 3A) .
Next, the activation of several components of the TLR2 signal transduction pathway was analyzed. The stress-linked kinases, p38 and JNK, were found to be phosphorylated within 15 and 30 min, and the phosphorylated forms persisted till 60 and 45 min, respectively, with no change in the total protein mass (Fig. 3B) . The figure also illustrates simultaneous phosphorylation and degradation of IjBa, an NF-jB inhibitor, within 30 min of PIL treatment.
As IjBa was degraded to almost non-detectable level at 45 min of PIL treatment, this time point was chosen for studying the nuclear translocation of NF-jB. Nuclei, prepared from DC treated with blank liposome or PIL, were used for the flow cytometric detection of nuclear translocation of the p65 member of NF-jB family. PIL-induced NF-jB translocation was 2.3-fold (2.25 6 0.06 SEM, P < 0.05) more than the untreated control (Fig. 3C) , suggesting that the transcription factor is responsible for PIL-mediated DC response. Pre-incubation of DC with neutralizing anti-TLR2 antibody was found to inhibit the nuclear translocation of NF-jB by 61.9% (Fig. 3D) , showing that the PIL-induced activity of NF-jB is TLR2 dependent.
Among the other members of the TLR2-signaling pathway, DC expressed the mRNA of MyD88, TRAF6 and NF-jB, which were 2.7-(2.68 6 0.19 SEM, P < 0.005), 1.7-(1.72 6 0.1 SEM, P < 0.05) and 2-fold (2.16 6 0.08 SEM, P < 0.05) higher, respectively, than the corresponding controls (Fig.  3E) . Treatment of DC with PIL had no effect on the MyD88 adaptor-like (Mal/TIRAP) mRNA expression. The data indicate that MyD88, TRAF6 and NF-jB are enhanced in DC in response to PIL for downstream signaling in tandem.
Up-regulation of MHC class II (I-A b ), CD40, CD80 and ICAM-1
We studied the surface expression of MHC class II, costimulatory molecules CD80-CD86, CD40 and ICAM-1 to Total RNA was extracted from the cells and subjected to RT-PCR using the corresponding primers of TLR1, 2 and 6. Ethidium bromide-stained PCR products were photographed and then images were digitized and analyzed. PCR products were quantified and expressed as the ratio of each product to GAPDH band density. The data given were obtained in one representative experiment out of three. The bar diagram shows mean 6 SEM of three independent experiments. *P < 0.05, **P < 0.005.
determine the adjuvant activity of PIL. Analysis of relative fluorescence intensity demonstrated that PIL induced MHC class II (I-A b ), CD40, CD80 and ICAM-1 on DC (Fig. 4) . The PIL-induced expression of MHC class II, CD40, CD80 and ICAM-1 was found to be 2.3-(2.3 6 0.01 SEM, P < 0.005), 2-(2.07 6 0.15 SEM, P < 0.05), 2-(2.08 6 0.17 SEM, P < 0.005) and 1.9-fold (1.91 6 0.01 SEM, P < 0.005) higher, respectively, than the corresponding controls. The inability of the protein to induce the expression of CD86 on CD11c + DC supports PIL-mediated selective up-regulation of the B7-1 (CD80) member of the B7 family.
Expression of type 1 chemokines and chemokine receptors PIL-treated DC expressed the mRNA for MIP-1a, MIP-1b and RANTES, the type 1 chemokines, that were 2-(1.
0.13 SEM, P < 0.05) more, respectively, than the controls (Fig. 5A) . MIP-3b/CCL19, involved in DC migration besides indicating polarization, was found to be up-regulated by 2-fold (2.01 6 0.05 SEM, P < 0.005). The mRNA expression of TARC, MDC and eotaxin-2 was down-regulated compared with the control, while that of IFN-inducible protein-10 (IP-10/CXCL10) and SLC remained unaltered. The data suggest that between the two pools of chemokines, representing either DC1 or DC2 phenotype, PIL induced DC to express the chemokines that indicate DC1 polarization and parallely down-regulated those involved in type 2 response.
CCR7 and CXCR4 are two of the chemokine receptors involved in migration of DC from peripheral tissue to the secondary lymphoid organ. Both CCR7 and CXCR4 were upregulated by 2-fold (2.06 6 0.14 SEM, P < 0.05; 2.01 6 0.09 SEM, P < 0.05) on DC in response to PIL (Fig. 5B) .
PIL-induced expression of intracellular TNF-a and IL-12
The cytokines analyzed in the present study were chosen for their critical role in determining DC polarization. Analysis of relative fluorescence intensity demonstrated that PIL induced 21% (20.9 6 1.55 SEM, P < 0.005) of the CD11c + cells to express TNF-a and 16% (16.42 6 2.08 SEM, P < 0.05) cells to express IL-12 (Fig. 6A) , the cytokines known for triggering type 1 response. No significant increase in IL-10-positive cells was found in response to PIL. Incubation of the cells with PIL plus IFN-c showed a significant increase in TNF-a-and IL-12-expressing cells, which were 1.5-and 2.1-fold more than those treated with PIL alone (Fig. 6B) . The bar diagram represents mean fluorescence intensity (MFI) of the cells as mean 6 SEM of three independent experiments. *P < 0.05. (E) DC were cultured with blank liposomes (L) or PIL for 24 h. Total RNA was extracted from the cells and subjected to RT-PCR using the corresponding primers of MyD88, TIRAP, TRAF6 and NF-jB. Ethidium bromide-stained PCR products were analyzed and expressed as the ratio of each product to GAPDH band density. The data given were obtained in one representative experiment out of three. The bar diagram represents mean 6 SEM of three independent experiments. *P < 0.05, **P < 0.005.
Quantification of IL-6, TNF-a and IL-12 release
One million DC released 90.07 pg of IL-6, 143.83 pg of TNFa and 50.34 pg of IL-12 p70 in response to PIL (Fig. 7A and  B) . Pre-incubation of DC with NF-jB-translocating inhibitor prior to PIL treatment inhibited the release of IL-6 and IL-12 by 100% and that of TNF-a by 91%. The data underline the importance of NF-jB in regulating IL-6 and the type 1 cytokines.
The cells treated with PIL plus IFN-c released 240.17 pg of TNF-a and 128.09 pg of IL-12 p70, which were 1.7-and 2.2-fold higher, respectively, than that by PIL alone, showing that IFN-c augmented the PIL-induced cytokine release (Fig. 7B) . Moreover, CD40 ligation by agonistic anti-CD40 antibody up-regulated PIL-mediated IL-12 p70 release to 239.5 pg, which was 5.4-fold higher than that released by PIL alone (Fig. 7C) . There was no effect of PIL on IL-10 release, even in the presence of anti-CD40 antibody.
TLR2 and simultaneous TLR2 and 6 knockdown inhibits PIL-induced response
We used TLR2 shRNA and TLR6 siRNA to knock down the expression of the two respective TLRs to show their importance as the key players in PIL-mediated activation and response of CD11c + JAWS II cells. The percent transfection efficiency was ;58 and 63% for TLR2 and TLR6, respectively, as evaluated by flow cytometric analysis of GFP or fluorescein in the cells 36 h post-transfection (Fig. 8A) . TLR2 and TLR6 expression of JAWS II cells was inhibited by 72 and 68% after transfection (Fig. 8B) . PIL-induced expression of CD40 and CD80 was down-regulated by 63 and 57% in TLR2 shRNA-transfected cells (Fig. 8C) , but only 38 and 29% in TLR6 siRNA-transfected cells (Fig. 8D) . Cells transfected for simultaneous knockdown of TLR2 and 6 showed 85 and 90% depletion in CD40 and CD80 expression (Fig. 8E) , suggesting the central role of TLR2 with TLR6 in maturation and activation of DC. Fifty-five, 70 and 60% drop in IL-6, TNF-a and IL-12 p70 release, respectively, showed that cytokine response of DC is TLR2 dependent (Fig. 8F) . In TLR6 siRNA-transfected cells, the release of IL-6, TNF-a and IL-12 p70 only dropped by 36, 45 and 32%, respectively. However, JAWS II cells transfected with both TLR2 shRNA and TLR6 siRNA showed strong inhibition of IL-6, TNF-a and IL-12 release by 81, 96 and 86%, respectively, thereby suggesting that TLR6 is more effective in combination with TLR2 to regulate PIL-mediated response of DC.
MyD88 knockdown blocks PIL-mediated cytokine release
The involvement of MyD88 in PIL-mediated signaling was examined by employing MyD88 siRNA to knock down the adaptor protein in CD11c
+ JAWS II cells. Flow cytometric analysis of fluorescein indicated ;62% transfection efficiency 36 h post-transfection (Fig. 9A) . Immunoblot analysis revealed the effective suppression of MyD88 expression in the cells transfected with MyD88 siRNA compared with nontransfected cells or that transfected with Negative Control siRNA (Fig. 9B) . Ninety, 86 and 80% depletion in IL-6, TNF-a and IL-12 release, respectively, in the transfected cells (Fig. 9C) indicated that PIL-induced cytokine response of DC is MyD88 dependent.
Stimulation of T cells by PIL-pulsed DC in allogeneic MLR
PIL-pulsed DC of C57BL/6 mice proliferated naive CD4 + T cells of BALB/c mice in allogeneic MLR, which was 5-fold more than control at the maximum stimulator concentration of 50 3 10 3 cells (Fig. 10A) . Flow cytometric analysis showed up-regulation of the activation molecules, CD69 and CD25 on CD4 + T cells by 4-fold (3.93 6 0.16 SEM, P < 0.05; 3.9 6 0.24 SEM, P < 0.05) (Fig. 10B) , thus suggesting that PIL-pulsed DC were potent stimulator of the naive T cells. The activated T cells released 142 pg of IFN-c per million cells with no change in IL-4 release (Fig. 10C) , indicating that PIL has an intrinsic ability to stimulate T cells to predominantly produce T h 1 cytokine.
Discussion
Earlier studies from our laboratory have unequivocally demonstrated that porin of S. dysenteriae type 1 activated antigenpresenting cell of inbred mice strains of different H2 haplotype, BALB/c, C57BL/6 and C3H/HeJ, resulting in upregulation of TLR2 and 6, expression of co-stimulatory (20, (23) (24) (25) . In line with these findings, porin was incorporated into liposome to study its adjuvant activity, as liposomes are well-defined systems that not only simulate the membrane environment but also retain the incorporated protein in its native form (6) . In this paper, it was addressed whether immunopotentiation by PIL could initiate the TLRsignaling pathway, leading to maturation and polarization of DC, and subsequently drive T cell activation, thereby linking innate and adaptive immunity. Previously, porin of S. dysenteriae was found to activate peritoneal macrophages and induce M1 polarization, which in turn skewed the naive T cells for T h 1-type response (20, 26) . In this study, murine DC were treated with homogeneous PIL since DC can initiate and regulate immune responses to infective structures and thus are a fundamental tool for adjuvant presentation. It has been postulated that TLRs are involved in regulating the effect of immune adjuvants (27) . Majority of the bacterial products is recognized by TLR2 and TLR4, other than CpG DNA by TLR9. We found that PIL-induced response of DC was TLR2 dependent. Besides TLR2, PIL up-regulated TLR6 similar to the known TLR2/TLR6 ligand FSL-1, with no effect on TLR1 and 4 expression, suggesting that co-expression of TLR2 and 6 is involved in recognition of PIL. The combination of TLRs recruited for recognizing an antigen may vary depending on the type of PAMP encountered, as neisserial porin expressed TLR2 and 1 (28), whereas porin of S. dysenteriae up-regulated TLR2 and 6.
Up-regulation of TLR2 in response to PIL led us to seek the signal transduction molecules that are activated by the receptor. Detection of the MyD88-TLR2 complex shows that the immunogen elicits the downstream-signaling molecules through MyD88-TLR2 association. This eventually leads to up-regulation of TRAF6, activation of MAPK and NF-jB, as evident from the phosphorylation of the stress kinases p38 and JNK, and nuclear translocation of the p65 member of NF-jB simultaneously with phosphorylation and degradation of its inhibitor, IjBa. Inhibition of the nuclear translocation of NF-jB by anti-TLR2 antibody strongly supports TLR2-mediated signaling in DC in response to PIL. These observations suggest that recognition of PIL by TLR2 is the key event that triggers the signaling pathway ultimately leading to activation of the pro-inflammatory transcription factor NF-jB along with the members of MAPK family for DC response.
Migration of DC to secondary lymphoid organ following TLR stimulation is a critical step that allows DC to encounter T cell to ensure effective antigen presentation. Adhesion molecules and chemokine receptors are known to play a major role in the process of migration (11) . Our data show that PIL induced the expression of CCR7 and CXCR4, indicating the ability of the immunogen to drive maturation and simultaneous migration of DC, which is critical for T cell activation. CCR7 is involved in migration of both DC and T cells, as naive T cells and mature DC positive for CCR7 move into T cell-rich areas in response to MIP-3b or SLC (14) . Among the CCR7 ligands, the expression of MIP-3b was upregulated by PIL while that of SLC remained unchanged. This not only indicates PIL-induced migration of CCR7-positive DC to T cell areas in response to MIP-3b but also suggests type 1 polarization of DC, as MIP-3b is found to be preferentially expressed by DC1 and SLC by DC2 (14) .
PIL showed the capacity to induce maturation of DC by up-regulating CD80, CD40 and MHC class II molecules. MHC and co-stimulatory molecules not only mark the maturation of DC but also participate in the formation of the immunological synapse to ensure better contact between DC and T cell for effective antigen presentation (29) . Adhesion molecule like ICAM-1 is also an active player of the synapse formation. Thus, PIL-induced expression of ICAM-1 along with the co-stimulatory molecules and MHC indicates that the mature DC prepares for an efficient interaction with T cells. In addition, ICAM-1 expression shows the bias for type 1 response as ICAM-1/leukocyte function-associated antigen-1 interaction is known to favor T h 1 cell polarization (30) . Apart from stabilizing DC-T cell interaction, ICAM-1 like other adhesion molecules is known for its critical role in DC migration.
PIL proved to be an efficient adjuvant by inducing maturation of DC and expressing the indicators which show its ability to support cell migration and drive type 1 response. Like peptidoglycan, a TLR2 agonist, PIL also failed to induce the expression of IP-10 (31), despite the significant augmentation in expression of the other type 1 chemokines MIP-1a, MIP-1b and RANTES. Our data not only show increased expression of T h 1-promoting chemokines but also demonstrate significant down-regulation of the T h 2-associated chemokines like TARC, MDC and eotaxin-2. This indicates that, by simultaneous stimulation of type 1 chemokines and suppression of the type 2 ones, PIL ensures a more effective type 1 response. T h 1 bias of PIL is further established by intracellular induction and release of TNF-a and IL-12 and their augmentation under the influence of IFN-c. Release of IL-12 was also enhanced by agonistic anti-CD40 antibody-mediated ligation of CD40, in support of the view that high level of IL-12 production requires two signals in the form of IFN-c and CD40 ligation (32) . Agonistic anti-CD40 antibody mimics the effect of CD40L by engaging CD40 on DC. In fact, CD40-CD40L interaction is believed to play a critical role in promoting both IL-10 and IL-12 production by DC (33) . However, PIL could not induce IL-10 release even under the influence of CD40 ligation. Engagement of CD40 by anti-CD40 antibody thus acts as an unbiased amplifier that promotes cytokine production, whose pattern had already been determined by the antigen. PIL-mediated release of the proinflammatory cytokine IL-6 by DC indicates its adjuvant effect, as IL-6 is known to induce B cell proliferation and Ig production (34) . Inhibition of IL-6, TNF-a and IL-12 release by NF-jB-translocating inhibitor points to the importance of the transcription factor in regulating the cytokines for an inflammatory type 1 response and also highlights the significance of TLR2, which had triggered NF-jB into action. The prime role of TLR2 in PIL-mediated activation and response of DC were established by TLR2 knockdown of CD11c + JAWS II cells, which down-regulated the expression of the maturation markers, CD40 and CD80 and inhibited the cytokine release. This inhibitory effect was augmented by simultaneous TLR2 and 6 knockdown, suggesting that the two TLRs participate as a combinatorial repertoire to activate the cells and release the pro-inflammatory cytokines. Furthermore, knockdown of MyD88, which inhibited IL-6, TNF-a and IL-12 release, indicates that the adaptor protein is directly involved in TLR2-and 6-mediated signaling.
This phenotypical and functional maturation of DC effectively activates the adaptive immune response as evident from the ability of PIL-pulsed DC to proliferate and activate naive allogeneic T cells. The CD4
+ T cells released IFN-c, the signature cytokine of T h 1 cells that indicates type 1 polarization of the immune response. The T h 1 bias of PIL is in contrast to Salmonella porin which induced lymphocytes to release IFN-c and IL-4 suggesting possibilities of both T h 1 and T h 2 responses (35) .
In summary, our study demonstrates the adjuvant property of PIL. The immunogen induced maturation and type 1 polarization of DC involving TLR2 and 6. PIL-stimulated DC activated the naive T cells to T h 1 phenotype. Since T h 1 response is critical for antimicrobial immunity (36), type 1 polarization constitutes an important aspect of vaccination strategies. Thus, the T h 1 bias of PIL establishes it as a potent adjuvant that successfully bridges innate and adaptive immune responses. 
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